The team managing the £25bn SLI Global Absolute Return Strategies (GARS) fund said outperformance in Asia negatively affected three of the portfolio's currency strategies over the first quarter of the year, leading them to close a number of positions.
Adam Rudd, investment director on the multi-asset investing team, said there were 11 positive contributors to the fund but ten positions were negative, leading to an overall negative return of 0.1% in...
BB Biotech's Head of Investment, Daniel Koller, explains why the sector's fundamentals are all lined up to the upside.
Classes A and D remain unavailable
Has been sponsor since 2010
Hires RBC's Martin Heale
Bringing over two funds